Name | GOT1 inhibitor-1 |
Synonyms | GOT1 inhibitor-1 GOT1 inhibitor 2c N-(4-chlorophenyl)-4-(1H-indol-4-yl)piperazine-1-carboxamide |
CAS | 732973-87-4 |
Molecular Formula | C19H19ClN4O |
Molar Mass | 354.83 |
Solubility | DMSO : 125 mg/mL (352.28 mM; Need ultrasonic)H2O : < 0.1 mg/mL (insoluble) |
Storage Condition | -20℃ |
Use | GOT1 inhibitor-1 (compound 2c) is a valeric acid derivative, which is a new, effective and non-covalent glutamate oxaloacetate transaminase 1 (GOT1) inhibitor with IC50 of 8.2 uM. GOT1 inhibitor-1 can be used for the study of pancreatic ductal adenocarcinoma (PDAC). |
In vitro study | PDAC tumors are dependent upon a metabolic pathway involving aspartate aminotransferase 1 (glutamate-oxaloacetate transaminase 1 (GOT1)), for the maintenance of redox homeostasis and sustained proliferation. Small molecule inhibitors targeting this metabolic pathway may provide a novel way for cancer research. In the MDH coupled GOT1 enzymatic assay, GOT1 inhibitor-1 shows an inhibitory effect on GOT1 activity with an IC 50 value of 8.2 uM. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.818 ml | 14.091 ml | 28.183 ml |
5 mM | 0.564 ml | 2.818 ml | 5.637 ml |
10 mM | 0.282 ml | 1.409 ml | 2.818 ml |
5 mM | 0.056 ml | 0.282 ml | 0.564 ml |